GAPVAC at SITC (Nov 7-11) in Washington, DC

We’re happy to announce, that GAPVAC will be part of the SITC Conference in Washington, DC (Nov 7-11). If you’re there, stop by and discuss with our experts newest trial results and scientific insights:

November 9th, 3:00pm-3:15pm

Talk: “The GAPVAC approach of actively personalized peptide vaccination for patients with newly diagnosed glioblastoma“

Speaker: Hideho Okada (University of California, San Francisco, USA and Parker Institute for Cancer Immunotherapy)

Session: Early Phase 1 Clinical Trials

 

November 10th, 12:20pm-1:50pm and 7:00pm-8:30pm

Poster: “The GAPVAC approach of actively personalized peptide vaccination for patients with newly diagnosed glioblastoma” (Abstract #O8)

Presenter: Norbert Hilf (Vice President Translational Development, Immatics Biotechnologies GmbH, Germany)

 

We’re looking forward to interesting and exciting discussions.

Further information about SITC here.